Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Head, L.
and
O'Keane, V.
1997.
Cost-effectiveness of antidepressant treatment.
British Journal of Psychiatry,
Vol. 171,
Issue. 1,
p.
88.
Woods, Scott W.
and
Baker, C. Bruce
1997.
Cost-effectiveness of newer antidepressants.
Current Opinion in Psychiatry,
Vol. 10,
Issue. 2,
p.
95.
Gilbody, Simon M
and
Petticrew, Mark
1999.
Rational decision-making in mental health: the role of systematic reviews.
The Journal of Mental Health Policy and Economics,
Vol. 2,
Issue. 3,
p.
99.
Araya, R.
1999.
The management of depression in primary health care.
Current Opinion in Psychiatry,
Vol. 12,
Issue. 1,
p.
103.
1999.
Cost-Effectiveness of Cyclic Antidepressants in a Developing Country.
Australian & New Zealand Journal of Psychiatry,
Vol. 33,
Issue. 2,
p.
283.
Croghan, Thomas W.
Johnstone, Bryan M.
Buesching, Don P.
and
Kessler, Ronald C.
1999.
Information Needs for Medication Coverage Decisions in a State Medicaid Program.
Medical Care,
Vol. 37,
Issue. ,
p.
AS24.
Hotopf, Matthew
Churchill, Rachel
and
Lewis, Glyn
1999.
Pragmatic randomised controlled trials in psychiatry.
British Journal of Psychiatry,
Vol. 175,
Issue. 3,
p.
217.
Crown, William H.
Hylan, Timothy R.
Montejo, Angel Luis
Sacristan, José A.
Gilaberte, Inmaculada
and
Meneades, Laurie
1999.
Manage or Perish?.
p.
277.
Mason, James
Eccles, Martin
Freemantle, Nick
and
Drummond, Michael
1999.
Incorporating economic analysis in evidence-based guidelines for mental health: the profile approach.
The Journal of Mental Health Policy and Economics,
Vol. 2,
Issue. 1,
p.
13.
Berndt, Ernst R.
Russell, James M.
Miceli, Robert
Colucci, Salvatore V.
Xu, Yikang
and
Grudzinski, Amy N.
2000.
Comparing SSRI Treatment Costs for Depression Using Retrospective Claims Data: The Role of Nonrandom Selection and Skewed Data.
Value in Health,
Vol. 3,
Issue. 3,
p.
208.
Woods, Scott W.
2000.
Pharmacoeconomic studies of antidepressants: Focus on venlafaxine.
Depression and Anxiety,
Vol. 12,
Issue. S1,
p.
102.
Butler, Rob
Collins, Elizabeth
Katona, Cornelius
and
Orrell, Martin
2000.
How do general practitioners select antidepressants for depressed elderly people?.
International Journal of Geriatric Psychiatry,
Vol. 15,
Issue. 7,
p.
610.
2000.
The educational challenge of mental health.
Medical Education,
Vol. 34,
Issue. 7,
p.
545.
Skaer, Tracy L.
Sclar, David A.
Robison, Linda M.
and
Galin, Richard S.
2000.
The Need for an Iterative Process for Assessing Economic Outcomes Associated with SSRIs.
PharmacoEconomics,
Vol. 18,
Issue. 3,
p.
205.
Goetzel, Ron Z.
Ozminkowski, Ronald J.
Meneades, Laurie
Stewart, Maureen
and
Schutt, David C.
2000.
Pharmaceuticals???Cost or Investment?.
Journal of Occupational and Environmental Medicine,
Vol. 42,
Issue. 4,
p.
338.
Paltiel, A. David
2001.
Model-Based Drug Evaluation in Chronic Disease: Promise, Pitfalls, and Positioning.
Drug Information Journal,
Vol. 35,
Issue. 1,
p.
131.
Kapur, Navneet
House, Allan
Dodgson, Kath
May, Chris
and
Creed, Francis
2001.
Hospital management and costs of antidepressant overdose: multicentre comparison of tricyclic antidepressants and selective serotonin reuptake inhibitors.
Journal of Medical Economics,
Vol. 4,
Issue. 1-4,
p.
193.
Peveler, Robert
and
Kendrick, Tony
2001.
Treatment delivery and guidelines in primary care.
British Medical Bulletin,
Vol. 57,
Issue. 1,
p.
193.
Baillargeon, Jacques
Black, Sandra A
Contreras, Salvador
Grady, James
and
Pulvino, John
2001.
Anti-depressant prescribing patterns for prison inmates with depressive disorders.
Journal of Affective Disorders,
Vol. 63,
Issue. 1-3,
p.
225.
Laux, G.
Eckert, A.
Müller, W. E.
Breyer-Pfaff, U.
Kasper, S.
Riedel, M.
Müller, N.
Möller, H. J.
Hiemke, C.
Schöchlin, C.
and
Engel, R. R.
2002.
Neuro-Psychopharmaka Ein Therapie-Handbuch.
p.
223.
eLetters
No eLetters have been published for this article.